Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Cochrane Review rejects safety concerns regarding cheap alternative drug for treating eye disease

Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.

16 Sep 2014

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.

15 Sep 2014

Professor receives award for development of anti-angiogenic therapy for retinal disease

Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.

11 Sep 2014

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world.

4 Sep 2014

New way to reduce abnormal blood vessel growth and leakage in eye

Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to the development of new drugs for wet macular degeneration and diabetic macular edema.

4 Sep 2014

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

The symptoms of dry eye disease include the sensation of grit in the eye, frequently accompanied by itching, burning and visual disturbance. The causes are poorly understood.

3 Sep 2014

iCo Therapeutics reports financial results for second quarter 2014

iCo Therapeutics, today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

29 Aug 2014

Reticular pseudodrusen predicts late-stage AMD

Reticular pseudodrusen increases the likelihood of people with choroidal neovascularisation in one eye also developing late-stage, age-related macular degeneration in the other eye, researchers report.

28 Aug 2014

Lifestyle factors modify vision impairment risk

Smoking, drinking alcohol and physical activity are modifiable behaviours that influence the risk of vision impairment, show findings from the Beaver Dam Eye Study.

28 Aug 2014

Simple colour test could detect early onset of nAMD in the UK

A simple colour test that could detect the early onset of a condition which accounts for over half of visual impairment certifications in the UK is being researched by scientists at Aston University.

28 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

Choroidal consequences differ between anti-VEGF therapies

Aflibercept’s possession of a fragment crystallisable region may make it more likely to induce unwanted effects in retinal and choroidal vessels than other anti-vascular endothelial growth factor therapies, say researchers.

20 Aug 2014

Risk factors for sporadic vision loss in AMD identified

Sporadic vision loss occurs in patients with age-related macular degeneration and impairs their future visual acuity, research shows.

20 Aug 2014

Focal choroidal excavation linked to chorioretinal diseases

Results of a Japanese study show that focal choroidal excavation is present in several ocular diseases, including typical age-related macular degeneration, central serous chorioretinopathy, polypoidal choroidal vasculopathy and idiopathic choroidal neovascularization.

20 Aug 2014

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Cochrane Review rejects safety concerns regarding cheap alternative drug for treating eye disease

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Professor receives award for development of anti-angiogenic therapy for retinal disease

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

New way to reduce abnormal blood vessel growth and leakage in eye

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

iCo Therapeutics reports financial results for second quarter 2014

Reticular pseudodrusen predicts late-stage AMD

Lifestyle factors modify vision impairment risk

Simple colour test could detect early onset of nAMD in the UK

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

Choroidal consequences differ between anti-VEGF therapies

Risk factors for sporadic vision loss in AMD identified

Focal choroidal excavation linked to chorioretinal diseases

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

FGF proteins play broad roles in wound healing

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Majority of adults need to double consumption of fruits and vegetables for crucial nutrition, health benefits

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in